PMHS (Polomar Health Services) EBIT: $-10.14 Mil (TTM As of Mar. 2026)


PMHS Polomar Health Services Inc PMHS
33 GF Score
Price $0.14
GF Value $12.34
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Polomar Health Services EBIT?

Polomar Health Services PMHS 33 EBIT is $-10.14 Mil as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 33/100 and a GF Value™ of $12.34 (Possible Value Trap). The stock has 3 warning signs investors should review.

Polomar Health Services's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-0.01 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-10.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Polomar Health Services's annualized ROC % for the quarter that ended in Mar. 2026 was -2.26%. Polomar Health Services's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -57.14%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Polomar Health Services's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -213.88%.

Polomar Health Services  (OTCPK:PMHS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Polomar Health Services's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-0.028 * ( 1 - 0% )/( (1.292 + 1.187)/ 2 )
=-0.028/1.2395
=-2.26 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.39 - 0.387 - ( 0.132 - max(0, 1.612 - 0.323+0.132))
=1.292

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.517 - 0.624 - ( 0.088 - max(0, 1.762 - 0.468+0.088))
=1.187

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Polomar Health Services's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.028/( ( (0.058 + max(-0.508, 0)) + (0.04 + max(-0.557, 0)) )/ 2 )
=-0.028/( ( 0.058 + 0.04 )/ 2 )
=-0.028/0.049
=-57.14 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.097 + 0.094 + 0) - (0.387 + 0.3 + 0.012)
=-0.508

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.171 + 0.209 + 5.5511151231258E-17) - (0.624 + 0.3 + 0.013)
=-0.557

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Polomar Health Services's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-10.142/4.742
=-213.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polomar Health Services EBIT Related Terms

Polomar Health Services EBIT Historical Data

* Premium members only.

The historical data trend for Polomar Health Services's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polomar Health Services EBIT Chart

Polomar Health Services Annual Data
Trend Dec07 Dec08 Dec09 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -0.02 -0.18 -0.59 -1.30 -10.55

Polomar Health Services Quarterly Data
Dec09 Mar10 Jun10 Sep10 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -0.56 -0.63 -8.94 -0.01

PMHS vs RDGT, DHTI, BLMH: EBIT Comparison

For the Pharmaceutical Retailers subindustry, Polomar Health Services's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polomar Health Services EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Polomar Health Services's EV-to-EBIT falls into.


PMHS
33GF Score
Polomar Health Services Inc PMHS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polomar Health Services EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-10.14 Mil mean?
Polomar Health Services (PMHS) has a EBIT of $-10.14 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Polomar Health Services.
Is Polomar Health Services' EBIT too high?
Polomar Health Services' current EBIT is $-10.14 Mil. Overall, Polomar Health Services has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' EBIT compare to RDGT and DHTI?
Polomar Health Services' EBIT of $-10.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Polomar Health Services. Polomar Health Services's current EBIT is $-10.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.34, compared to a current price of $0.14 — trading 98.8% below its estimated fair value. The current EBIT is $-10.14 Mil. Polomar Health Services' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current EBIT is $-10.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polomar Health Services (PMHS) Overvalued in 2026?

Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued. The current stock price of $0.14 is trading 98.8% below its estimated GF Value™ of $12.34. GuruFocus considers Polomar Health Services to be Possible Value Trap.

Key valuation signals for PMHS:

  • EBIT: $-10.14 Mil
  • GF Value™: $12.34 vs. price of $0.14 (98.8% below fair value)
  • GF Score™: 33/100 with 3 warning signs

No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polomar Health Services Business Description

Address 32866 US Highway, 19 N, Los Angeles, FL, USA, 34684
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
33GF Score

Get the complete analysis for PMHS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$12.34
GF Value